GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment GeNeuro, 18 Dec 2015 Accessed on 22 Dec 2015 from http://www.geneuro.com/en/news/press_articles.php. CommentRecommendBookmarkWatch